These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27015085)

  • 1. Metabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular Function.
    Sandlers Y; Mercier K; Pathmasiri W; Carlson J; McRitchie S; Sumner S; Vernon HJ
    PLoS One; 2016; 11(3):e0151802. PubMed ID: 27015085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
    Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin/cardiolipin ratio.
    Vaz FM; van Lenthe H; Vervaart MAT; Stet FS; Klinkspoor JH; Vernon HJ; Goorden SMI; Houtkooper RH; Kulik W; Wanders RJA
    J Inherit Metab Dis; 2022 Jan; 45(1):29-37. PubMed ID: 34382226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical laboratory studies in Barth Syndrome.
    Vernon HJ; Sandlers Y; McClellan R; Kelley RI
    Mol Genet Metab; 2014 Jun; 112(2):143-7. PubMed ID: 24751896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
    Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
    Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution mass spectrometric analysis of cardiolipin profiles in Barth syndrome.
    Byeon SK; Ramarajan MG; Madugundu AK; Oglesbee D; Vernon HJ; Pandey A
    Mitochondrion; 2021 Sep; 60():27-32. PubMed ID: 34273557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.
    Zegallai HM; Hatch GM
    Mol Cell Biochem; 2021 Mar; 476(3):1605-1629. PubMed ID: 33415565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis.
    Bowron A; Frost R; Powers VE; Thomas PH; Heales SJ; Steward CG
    J Inherit Metab Dis; 2013 Sep; 36(5):741-6. PubMed ID: 23109063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype.
    Bowron A; Honeychurch J; Williams M; Tsai-Goodman B; Clayton N; Jones L; Shortland GJ; Qureshi SA; Heales SJ; Steward CG
    J Inherit Metab Dis; 2015 Mar; 38(2):279-86. PubMed ID: 25112388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New targets for monitoring and therapy in Barth syndrome.
    Thompson WR; DeCroes B; McClellan R; Rubens J; Vaz FM; Kristaponis K; Avramopoulos D; Vernon HJ
    Genet Med; 2016 Oct; 18(10):1001-10. PubMed ID: 26845103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiolipin remodeling in Barth syndrome and other hereditary cardiomyopathies.
    Bertero E; Kutschka I; Maack C; Dudek J
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165803. PubMed ID: 32348916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and natural history of Barth Syndrome: An overview.
    Taylor C; Rao ES; Pierre G; Chronopoulou E; Hornby B; Heyman A; Vernon HJ
    J Inherit Metab Dis; 2022 Jan; 45(1):7-16. PubMed ID: 34355402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-chain fatty acid oxidation and respiratory complex I deficiencies distinguish Barth Syndrome from idiopathic pediatric cardiomyopathy.
    Chatfield KC; Sparagna GC; Specht KS; Whitcomb LA; Omar AK; Miyamoto SD; Wolfe LM; Chicco AJ
    J Inherit Metab Dis; 2022 Jan; 45(1):111-124. PubMed ID: 34821394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
    Ye C; Shen Z; Greenberg ML
    J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of plasmalogen biosynthesis reverse lipid changes in a Barth Syndrome cell model.
    Bozelli JC; Lu D; Atilla-Gokcumen GE; Epand RM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158677. PubMed ID: 32126285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome.
    Petit PX; Ardilla-Osorio H; Penalvia L; Rainey NE
    Cells; 2020 Oct; 9(10):. PubMed ID: 33096711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome.
    Kiebish MA; Yang K; Liu X; Mancuso DJ; Guan S; Zhao Z; Sims HF; Cerqua R; Cade WT; Han X; Gross RW
    J Lipid Res; 2013 May; 54(5):1312-25. PubMed ID: 23410936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiolipin fingerprinting of leukocytes by MALDI-TOF/MS as a screening tool for Barth syndrome.
    Angelini R; Lobasso S; Gorgoglione R; Bowron A; Steward CG; Corcelli A
    J Lipid Res; 2015 Sep; 56(9):1787-94. PubMed ID: 26144817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome.
    Gaspard GJ; McMaster CR
    Chem Phys Lipids; 2015 Dec; 193():1-10. PubMed ID: 26415690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF21 and GDF15 are elevated in Barth Syndrome and are correlated to important clinical measures.
    Liu O; Chinni BK; Manlhiot C; Vernon HJ
    Mol Genet Metab; 2023 Nov; 140(3):107676. PubMed ID: 37549445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.